Year
Year
Value
Sector
Saski Partners, part of Corporate Finance International, acted as the sole financial adviser to the shareholder of MyBestPharm S.A. on the sale of 100% stake to Urgo Sp. z o. o.
Founded in 2021, MyBestPharm S.A. is a leading digitally native Polish brand specializing in premium food supplements, functional foods, and dermocosmetics. In just four years, the company has built a strong product portfolio distinguished by sophisticated formulations, high active ingredient dosages, and rigorous testing. Its bestsellers include MyBestBeauty+, MyBestProtect, and MyBestComplement. With the support of Urgo Healthcare, MyBestPharm plans to accelerate its growth both in Poland and internationally, targeting a doubling of turnover by 2030.
Urgo Healthcare, part of the French family-owned Urgo Group, is a major player in everyday healthcare, known for iconic brands such as Urgo, Alvityl, Humer, and Belloc. As a leader in primary care, food supplements, and hygiene, Urgo Healthcare continues to strengthen its European footprint, with Poland being one of its most dynamic markets.
Transactions
Adviser to the seller
Saski Partners Sp. z o.o. sp. k.
ul. Śniadeckich 10, 4-th floor
00-656 Warsaw
Phone.: +48 22 218 5900
E-mail: biuro@saskipartners.pl
corporate finance · mergers and acquisitions · fundraising · financial restructuring · strategic financial advice · equity financing · debt financing · private equity · private debt · refinancing · estate planning · family office · company strategy · company disposal · company purchase · financial model · valuation · issued shares · bond issue · leveraged buyote · management buyout
© Saski Partners. All Rights Reserved | Legal Disclaimer / Cookies